Radiation-associated breast angiosarcomas are associated with poor clinical outcomes including high recurrence rates and poor survival.
RT-AS portends high recurrence and poor survival; leaves open need for novel therapies in this rare entity.
RT-AS has high local/distant recurrence rates, limited duration on standard chemotherapy and poor disease-specific survival.
No takes yet. Share an insight, caveat, or question.
D’Angelo et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: